Musculoskeletal Diseases Market By Type 2022 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Musculoskeletal Diseases Market
Musculoskeletal Diseases Market: By Type (Rheumatoid Arthritis, Osteoarthritis, Psoriatic Arthritis, Ankylosing Spondylitis and Others); By Treatment (Biologics, Corticosteroids, Parathyroid Hormone, Protein Therapy, Selective Estrogen Receptor Modulators and Others) & By Region - (2016-2022)
Report Code : HCR 0323
Updated Date: 11 September, 2017  

Copies sold

    Client Rating

  • Report Description
  • Table of Contents
  • Customization Options
1. Musculoskeletal Diseases Market Overview
2. Musculoskeletal Diseases Market Executive Summary
3. Musculoskeletal Diseases Market Landscape 
   3.1. Market Share Analysis
   3.2. Financial Analysis
   3.3. Patent Analysis
   3.4. Competitor  Analysis 
4. Musculoskeletal Diseases Market Forces
   4.1. Market Drivers
      4.1.1. Continual Development of Efficient and Advance Technology May Propel the Growth of this Market
      4.1.2. Development and Commercialization of Pipeline Drugs 
      4.1.3. The Increasing Need for Development of Drugs that can Enhance the Bone Density and Rebuild the Lost Bone and its Strength 
      4.1.4. Significant Improvement in Patient Health by Using Combination Therapies Will Foster the Growth 
      4.1.5. High Growth Potential of Mabs (Monoclonal Antibodies) will Upsurge the Growth
   4.2. Market Constraints & Challenges
      4.2.1. High Cost of Research and Development 
      4.2.2. Non-Adherence to Treatment Regimen
      4.2.3. Strict Drug Approval by Regulatory Bodies to Pose Challenges 
      4.2.4. The Doubt of Side Effects May Lower the Demand
   4.3. Attractiveness of Musculoskeletal Diseases Market 
      4.3.1. Power of Suppliers
      4.3.2. Power of Buyers
      4.3.3. Threat of Substitutes
      4.3.4. Threat of New entrants
      4.3.5. Degree of Competitive Rivalry
5. Musculoskeletal Diseases Market – Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Opportunities Analysis
      5.2.1. The Ample Presence of Unmet Medical Needs specifically in Emerging Economies 
      5.2.2. Increasing Prevalence of Musculoskeletal Disease Across the Globe
      5.2.3. Increasing Government Initiative Across The Globe
   5.3. Market Life Cycle Analysis
6. Musculoskeletal Diseases Market–  By  Type
   6.1. Introduction 
   6.2. Rheumatoid Arthritis 
   6.3. Osteoarthritis 
   6.4. Osteoporosis
   6.5. Psoriatic Arthritis 
   6.6. Ankylosing Spondylitis 
   6.7. Fibromyalgia
   6.8. Others
7. Musculoskeletal Diseases Market–  By Treatment
   7.1. Introduction
   7.2. Biologics 
   7.3. Corticosteroids 
   7.4. Parathyroid Hormone 
   7.5. Protein Therapy
   7.6. Selective Estrogen Receptor Modulators
   7.7. Synthetic Bone Graft
   7.8. Composite Grafts
   7.9. Demineralized Bone Matrix
   7.10. BMPS
8. Musculoskeletal Diseases Market- By Geography
   8.1. Introduction
   8.2. North America 
      8.2.1. U.S
      8.2.2. Canada 
      8.2.3. Mexico
   8.3. Europe
      8.3.1. U.K.
      8.3.2. France
      8.3.3. Germany
      8.3.4. Italy
      8.3.5. Spain
      8.3.6. Rest of Europe
   8.4. Asia-Pacific
      8.4.1. China
      8.4.2. Japan
      8.4.3. India
      8.4.4. Australia & New Zealand
      8.4.5. Rest of APAC
   8.5. RoW
      8.5.1. Africa
      8.5.2. Middle East
      8.5.3. South America
9. Musculoskeletal Diseases Market Entropy
10. Musculoskeletal Diseases Market Company Profiles 
   10.1. Abbvie Inc. (U.S.)
   10.2. Eli Lilly and Company (U.S.)
   10.3. Johnson & Johnson Private Limited (U.S.)
   10.4. Medtronic PLC(U.S.)
   10.5. Nuvasive, Inc. (U.S.)
   10.6. Smith & Nephew(U.K.)
   10.7. Stryker Corporation(U.S.)
   10.8. Wright Medical (U.S.)
   10.9. Zimmer Biomet Holdings, Inc. (U.S.)
*More than 10 Companies are profiled in this Research Report*
"*Financials would be provided on a best efforts basis for private companies"
The Human musculoskeletal system is an organ system that enables humans to move or perform some activity with their muscles and skeletal system. The pain or injuries in the human musculoskeletal system including joints and ligaments are termed as musculoskeletal diseases or disorders. Musculoskeletal diseases can affect many different parts of the body and can be treated by innovative technologies evolved in recent times. However, one of the challenges affecting the market growth is consumer concerns on side effect caused by treatment. The global musculoskeletal diseases market is thus estimated to grow at a CAGR of 5.5% during the forecast period of 2017-2022 and reach revenue of $XXm by 2022.

The report analyzes the musculoskeletal diseases market by disease type and by treatment. Disease types covered in the report are rheumatoid arthritis, osteoarthritis, osteoporosis, psoriatic arthritis, ankylosing spondylitis and fibromyalgia. Rheumatoid arthritis is estimated to hold major share for musculoskeletal diseases market throughout the forecast period. The musculoskeletal diseases market is also segmented by type of treatments on musculoskeletal diseases which includes biologics, corticosteroids, parathyroid hormone, protein therapy, selective estrogen receptor modulators, synthetic Bone graft, composite grafts, demineralized bone matrix and BMPS. The report estimates the size of the global market in terms of value ($Bn). 

Musculoskeletal Diseases Market

The report provides market size and forecast for the regions of North America, Europe, APAC and RoW. A detailed qualitative analysis of the factors responsible for driving and restraining growth of the fresh food packaging market and future opportunities are provided in the report. The report profiles nine key players of the musculoskeletal diseases market. 

Sample Companies Profiled in this Report are:
  • Johnson & Johnson Private Limited (U.S.)
  • Zimmer Biomet Holdings, Inc. (U.S.)
  • Stryker Corporation (U.S.)
  • Medtronic PLC (U.S.) 
  • 10+
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports